Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2025-12-24 @ 11:10 PM
NCT ID:
NCT06762769
Brief Title:
Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma
Official Title:
Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma
Acronym:
MODIFY
Study:
NCT06762769
Protocol Section:
NCT06762769